Anti-Hypertensive Drugs Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2017 - 2025, the global anti-hypertensive drugs market was valued at USD 32,987.4 Mn in 2017, and is expected to reach USD 39,116.7 Mn by 2025, expanding at a CAGR of 1.2% from 2017 to 2025.
Browse Full Report Visit - http://www.acutemarketreports.com/report/anti-hypertensive-drugs-market
Market Insights
Hypertension is commonly observed chronic condition, in which the blood pressure is elevated abnormally both systolic and diastolic. This is major risk factor for causing cardiovascular, renal or endocrine disorder. The normal blood pressure level is 120-140mm Hg systolic and 60-90mm Hg diastolic any elevation above it is considered as hypertension. The major reason for the rise in prevalence of hypertension is lifestyle change, unhealthy food habits and demographic ageing. Anti-hypertensive drugs are used to reduce the level of blood pressure, different drug class of drugs with different mechanism of action exist in the market. The antihypertensive market is growing with increased patient pool especially geriatric population and extensive research and development for novel pipeline drug. The global antihypertensive market show robust growth in forecast period, but it face threat of genericization and increased competition due to patent expiry.
Anti-Hypertensive are categorized by drug class type as Diuretics, Angiotensin receptor blockers (ARBs), Angiotensin converting enzyme (ACE) inhibitors, Beta blockers, Alpha blockers, Calcium channel blockers, Renin inhibitors and Vasodilators. ACE inhibitor occupies the largest market share in terms of value due to mechanism of action and is preferred in geriatric population and diabetes patient as first line of treatment as antihypertensive drug. Beta blockers follow next in line due to preference of physician over diuretic, which are most commonly used.
Based on the drug class type, the global Anti-hypertensive drugs market is segmented as follows:
• Diuretics
• ACE inhibitors
• ARBs
• Calcium Channel Blockers
• Beta - Adrenergic blocker
• Alpha - Adrenergic blocker
• Central Sympatholyics
• Renin inhibitors
• Vasodilators
• ACE inhibitors
• ARBs
• Calcium Channel Blockers
• Beta - Adrenergic blocker
• Alpha - Adrenergic blocker
• Central Sympatholyics
• Renin inhibitors
• Vasodilators
As of the current market scenario, North America is the largest regional market for anti-hypertensive drugs market, followed by the Europe and Asia Pacific. The major factors driving the North America rise in prevalence of hypertension and other associated chronic disease especially in geriatric population, novel drugs in pipeline and upcoming use of combination therapies. Europe major market contributor are UK, Germany, France, Italy and Spain due to factors such as increase in prevalence of hypertension and unmet need for treatment of chronic disease, health care program planning and expenditure. Asia-Pacific is the fastest growing market due to rise population and incidence of chronic diseases due to alteration in lifestyle changes; and health care infrastructure and government expenditure. Thus developed market dominates the antihypertensive drugs market, with developing economies booming at fast rate.
Browse All Reports of This Category - http://www.acutemarketreports.com/category/market-research
Market Competition Assessment:
Key players in the global Anti-Hypertensive drugs market are
Novartis AG, Astra Zeneca, Pfizer Inc., Acetelion Ltd, Sanofi S.A., Merck & Co., Boehringer Ingelheim, Lupin Limited, Johnson & Johnson Ltd., Astra Zeneca Plc, Daiichi Sankyo Company Limited and Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceutical, Bayer AG etc.
Novartis AG, Astra Zeneca, Pfizer Inc., Acetelion Ltd, Sanofi S.A., Merck & Co., Boehringer Ingelheim, Lupin Limited, Johnson & Johnson Ltd., Astra Zeneca Plc, Daiichi Sankyo Company Limited and Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceutical, Bayer AG etc.
Key Market Movements:
• Rising prevalence of hypertension due to various factors such as growing population, change in unhealthy lifestyle etc.
• Extensive R&D for new treatment regimen and new drug approval in pipeline
• Evolving use of combination therapy to lower the blood pressure and decrease in adverse effect
• Extensive R&D for new treatment regimen and new drug approval in pipeline
• Evolving use of combination therapy to lower the blood pressure and decrease in adverse effect
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Anti-Hypertensive Drugs Market Portraiture
2.2 Global Anti-Hypertensive Drugs Market Share, by Drug type, 2015 (US$ Mn)
2.3 Global Anti-Hypertensive Drugs Market, by Geography, 2015 (Value %)
2.1 Global Anti-Hypertensive Drugs Market Portraiture
2.2 Global Anti-Hypertensive Drugs Market Share, by Drug type, 2015 (US$ Mn)
2.3 Global Anti-Hypertensive Drugs Market, by Geography, 2015 (Value %)
Chapter 3 Global Anti-Hypertensive Drugs Market Analysis
3.1 Hypertension
3.1.1 Epidemiology
3.1.2 Treatment
3.2 Prescription Analysis
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Prevalence of chronic diseases
3.3.1.2 Rise in R&D and new drug approval
3.3.2 Challenges
3.3.2.1 Adverse effects of anti-hypertensive
3.3.3 Opportunities
3.3.3.1 Use of combination therapy and to address the unmet needs
3.4 Attractive Investment Proposition
3.5 Pipeline Analysis
3.6 Market Positioning of Key Players in Anti-Hypertensive Drugs
3.1 Hypertension
3.1.1 Epidemiology
3.1.2 Treatment
3.2 Prescription Analysis
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Prevalence of chronic diseases
3.3.1.2 Rise in R&D and new drug approval
3.3.2 Challenges
3.3.2.1 Adverse effects of anti-hypertensive
3.3.3 Opportunities
3.3.3.1 Use of combination therapy and to address the unmet needs
3.4 Attractive Investment Proposition
3.5 Pipeline Analysis
3.6 Market Positioning of Key Players in Anti-Hypertensive Drugs
To Get Complete Report @ http://www.acutemarketreports.com/report/anti-hypertensive-drugs-market
Chapter 4 Global Anti-Hypertensive Drugs Market Analysis, by Drug Type, 2015 - 2025 (US$ Mn)
4.1 Introduction
4.2 Diuretics
4.3 ACE inhibitors
4.4 ARBs
4.5 Calcium Channel Blockers
4.6 Beta - Adrenergic blocker
4.7 Alpha - Adrenergic blocker
4.8 Central Sympatholyics
4.9 Renin inhibitors
4.10 Vasodilators
4.1 Introduction
4.2 Diuretics
4.3 ACE inhibitors
4.4 ARBs
4.5 Calcium Channel Blockers
4.6 Beta - Adrenergic blocker
4.7 Alpha - Adrenergic blocker
4.8 Central Sympatholyics
4.9 Renin inhibitors
4.10 Vasodilators
Chapter 5 Global Anti-Hypertensive Drugs Market, by Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan, and Rest of APAC)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.6 Middle East and Africa (UAE, Saudi Arabia, South Africa)
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan, and Rest of APAC)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.6 Middle East and Africa (UAE, Saudi Arabia, South Africa)
Latest Reports :
http://www.acutemarketreports.com/report/3d-bioprinters-market
http://www.acutemarketreports.com/report/3d-bioprinters-market
Our Blog :- http://www.allbizreports.com/
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
